Literature DB >> 23348702

Pharmacological inhibition of carbonic anhydrase XII interferes with cell proliferation and induces cell apoptosis in T-cell lymphomas.

Nadia Lounnas1, Célia Rosilio, Marielle Nebout, Didier Mary, Emmanuel Griessinger, Zouhour Neffati, Johanna Chiche, Hergen Spits, Thijs J Hagenbeek, Vahid Asnafi, Sally-Ann Poulsen, Claudiu T Supuran, Jean-François Peyron, Véronique Imbert.   

Abstract

The membrane-bound carbonic anhydrase isoforms CAIX and CAXII, underpin a pH-regulating system that enables hypoxic tumor cell survival. Here, we observed for the first time an upregulation of CAXII in T-cell acute lymphoblastic leukemia/lymphoma (T-ALL/LL) cells. First we showed that CAXII is overexpressed in thymocytes from tPTEN-/- mice suffering of T lymphoma and that its pharmacological inhibition decreased cell proliferation and induced apoptosis. The same results were observed with the SupT1 human T cell lymphoma line. In addition we observed an upregulation of CAXII in human T-ALL samples supporting the case that CAXII may represent a new therapeutic target for T-ALL/LL.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23348702     DOI: 10.1016/j.canlet.2013.01.020

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  10 in total

Review 1.  Post-translational modifications in tumor-associated carbonic anhydrases.

Authors:  Anna Di Fiore; Claudiu T Supuran; Andrea Scaloni; Giuseppina De Simone
Journal:  Amino Acids       Date:  2021-08-26       Impact factor: 3.520

2.  Advances in Anti-Cancer Drug Development Targeting Carbonic Anhydrase IX and XII.

Authors:  Mam Y Mboge; Robert McKenna; Susan C Frost
Journal:  Top Anticancer Res       Date:  2015

3.  Recent Advances in Targeting Tumor Energy Metabolism with Tumor Acidosis as a Biomarker of Drug Efficacy.

Authors:  Paul J Akhenblit; Mark D Pagel
Journal:  J Cancer Sci Ther       Date:  2016

Review 4.  Carbonic Anhydrases: Role in pH Control and Cancer.

Authors:  Mam Y Mboge; Brian P Mahon; Robert McKenna; Susan C Frost
Journal:  Metabolites       Date:  2018-02-28

5.  Crucial role of carbonic anhydrase IX in tumorigenicity of xenotransplanted adult T-cell leukemia-derived cells.

Authors:  Kentaro Nasu; Kazunori Yamaguchi; Tomoka Takanashi; Keiichi Tamai; Ikuro Sato; Shoji Ine; Osamu Sasaki; Kennichi Satoh; Nobuyuki Tanaka; Yuetsu Tanaka; Takuya Fukushima; Hideo Harigae; Kazuo Sugamura
Journal:  Cancer Sci       Date:  2017-03       Impact factor: 6.716

6.  Inhibitory Monoclonal Antibodies and Their Recombinant Derivatives Targeting Surface-Exposed Carbonic Anhydrase XII on Cancer Cells.

Authors:  Dovile Stravinskiene; Aiste Sliziene; Lina Baranauskiene; Vilma Petrikaite; Aurelija Zvirbliene
Journal:  Int J Mol Sci       Date:  2020-12-10       Impact factor: 5.923

7.  Tiliroside as a CAXII inhibitor suppresses liver cancer development and modulates E2Fs/Caspase-3 axis.

Authors:  Rui Han; Hongxing Yang; Lingeng Lu; Lizhu Lin
Journal:  Sci Rep       Date:  2021-04-21       Impact factor: 4.379

Review 8.  Experimental Carbonic Anhydrase Inhibitors for the Treatment of Hypoxic Tumors.

Authors:  Claudiu T Supuran
Journal:  J Exp Pharmacol       Date:  2020-12-15

9.  Pharmacological inhibition of Carbonic Anhydrase IX and XII to enhance targeting of acute myeloid leukaemia cells under hypoxic conditions.

Authors:  Fangli Chen; Emilia Licarete; Xue Wu; Daniela Petrusca; Callista Maguire; Max Jacobsen; Austyn Colter; George E Sandusky; Magdalena Czader; Maegan L Capitano; James P Ropa; H Scott Boswell; Fabrizio Carta; Claudiu T Supuran; Brian Parkin; Melissa L Fishel; Heiko Konig
Journal:  J Cell Mol Med       Date:  2021-11-17       Impact factor: 5.310

10.  Novel insights on saccharin- and acesulfame-based carbonic anhydrase inhibitors: design, synthesis, modelling investigations and biological activity evaluation.

Authors:  Paolo Guglielmi; Giulia Rotondi; Daniela Secci; Andrea Angeli; Paola Chimenti; Alessio Nocentini; Alessandro Bonardi; Paola Gratteri; Simone Carradori; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.